Michael A. Griffith is a Senior Advisor of ACP, focused on investment opportunities in the Pharmaceutical Services sector. Michael is a proven executive with over 20 years of experience running businesses that provide agency regulated outsourced services to pharmaceutical clients. He is currently President and CEO of ACP’s portfolio investment, Amplity Health. Prior to joining Amplity, Michael was an Operating Partner at ACP.
Before joining ACP, Michael was President of the Commercial Division of inVentiv Health, a leading global provider of biopharmaceutical outsourcing services across the continuum of research and commercialization of drugs. Prior to inVentiv, he was CEO at Laureate Biopharma, a contract development and manufacturing company specializing in protein therapeutics; Founder and CEO of Aptuit, a global contract drug development company; and Chairman and CEO of ChiRex, a global contract development and manufacturing business. Michael has served on numerous public company boards including the board of Repligen Corporation, and he is currently Executive Chairman of HealthPrize Technologies. He started his career at Credit Suisse First Boston and Bankers Trust Company in New York.
Michael earned his Masters of Management from Northwestern University’s Kellogg Graduate School of Management, and received his B.S. degree in Business Administration from the University of Kansas.